NIH-funded research R01 grant

GCN2 and amino acid restriction in abdominal aortic aneurysm

Official title: The Role of Amino Acid Starvation Response Kinase GCN2 in Abdominal Aortic Aneurysm

Funded at Northwestern University · NIH-11295475 · Data updated 2026-11-12

This project looks at how a cellular stress pathway called GCN2, activated by limiting amino acids, might help slow or prevent abdominal aortic aneurysm in people at risk.

More Aneurysm research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNorthwestern University
NIH-funded
Lab location1 site (Chicago, United States)
Project startApril 1, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$391,565
NIH project number5R01HL162895-05
Project IDNIH-11295475 on NIH RePORTER

Who could benefit from this research

Could help

Patients with or at risk for abdominal aortic aneurysm who are seeking non-surgical management options and can tolerate dietary modification or related interventions.

Less likely to help

Individuals without AAA or without interest in dietary/drug strategies to influence AAA progression may not benefit.

What this research studies

Abdominal aortic aneurysm is a dangerous condition with few drug options. The study builds on animal findings that restricting certain amino acids could activate a protective stress response via GCN2, potentially stabilizing the aorta. Researchers will translate these ideas toward human relevance by examining how GCN2 activity relates to vessel health and testing strategies that could be safe for patients. The goal is to identify non-surgical approaches to contain AAA progression and improve outcomes for patients who are not candidates for immediate repair.

Why it matters

Potential benefit: If successful, the work could lead to new dietary- or drug-based strategies to slow AAA progression and reduce rupture risk.

How similar studies have gone: Preclinical studies in animal models have shown that amino acid restriction and GCN2 activation can influence AAA development, with human data suggesting lower GCN2 activity in AAA tissue; translation to patients remains to be established.

Where this research is happening

  • Northwestern University
    Chicago, United States
    Active

Researchers

  • Principal investigator: Wang, Bowen — Northwestern University
  • Study coordinator: Wang, Bowen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.